Kandelaria M. Rumilla

Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma

Evanthia Galanis, Svetomir N. Markovic, Vera J. Suman et al. · Molecular Therapy · 2012 · 171 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

BRAF V600E Expression in Langerhans Cell Histiocytosis

Anja C. Roden, Xiaowen Hu, Sertac Kip et al. · The American Journal of Surgical Pathology · 2014 · 159 citations

Medicine, Molecular Genetics, Pathology +13

A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome

Maegan E. Roberts, Douglas L. Riegert‐Johnson, Brittany C. Thomas et al. · Genetics in Medicine · 2014 · 142 citations · Full text

Veterinary Medicine, Oncology, Pathology +15

Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study

Ashish V. Chintakuntlawar, Kandelaria M. Rumilla, Carin Y. Smith et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 135 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases

Kandelaria M. Rumilla, Karen V. Schowalter, Noralane M. Lindor et al. · Journal of Molecular Diagnostics · 2011 · 100 citations · Full text

Medicine, Molecular Genetics, Oncology +5